subetta
Biologicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started May 1, 2013 (NCT01868594)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Sulfonylurea receptor 1Immunity, passive
ABCC8 immunity, passive
- Nitric oxide synthase, endothelialImmunity, passive
NOS3 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- subetta
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03725033 | Phase 3 | Oct 10, 2018 | Materia Medica Holding |
| NCT01868594 | Phase 4 | May 1, 2013 | Materia Medica Holding |
| NCT01868646 | Phase 4 | May 1, 2013 | Materia Medica Holding |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Materia Medica Holding | For profit | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1